742
Views
9
CrossRef citations to date
0
Altmetric
Editorial

Subjective tolerability of antipsychotic medications and the emerging science of subjective tolerability disorders

Pages 1-4 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Daniel S. Helman. (2018) Recovery from Schizophrenia: An Autoethnography. Deviant Behavior 39:3, pages 380-399.
Read now
A George Awad. (2015) ‘The patient’: at the center of patient-reported outcomes. Expert Review of Pharmacoeconomics & Outcomes Research 15:5, pages 729-731.
Read now

Articles from other publishers (7)

Xia Zhou, Xiaolan Wang, Rui Li, Jun Yan, Ying Xiao, Weiguang Li & Hong Shen. (2020) Neutrophil-to-Lymphocyte Ratio Is Independently Associated With Severe Psychopathology in Schizophrenia and Is Changed by Antipsychotic Administration: A Large-Scale Cross-Sectional Retrospective Study. Frontiers in Psychiatry 11.
Crossref
Daniel S. Helman. (2020) Nonmedical Interventions for Schizophrenia. Holistic Nursing Practice 34:2, pages 73-82.
Crossref
A. George Awad. (2018) Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later. CNS Drugs 33:1, pages 1-8.
Crossref
André Aleman, Tania M. Lincoln, Richard Bruggeman, Ingrid Melle, Johan Arends, Celso Arango & Henderikus Knegtering. (2017) Treatment of negative symptoms: Where do we stand, and where do we go?. Schizophrenia Research 186, pages 55-62.
Crossref
George Awad, Mariam Hassan, Antony Loebel, Jay Hsu, Andrei Pikalov & Krithika Rajagopalan. (2014) Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia. BMC Psychiatry 14:1.
Crossref
Gustav Bizik, Martin Picard, Rami Nijjar, Valérie Tourjman, Bruce S. McEwen, Sonia J. Lupien & Robert-Paul Juster. (2013) Allostatic Load as a Tool for Monitoring Physiological Dysregulations and Comorbidities in Patients with Severe Mental Illnesses. Harvard Review of Psychiatry 21:6, pages 296-313.
Crossref
A. George Awad & Lakshmi N. P. Voruganti. (2013) The Impact of Newer Atypical Antipsychotics on Patient-Reported Outcomes in Schizophrenia. CNS Drugs 27:8, pages 625-636.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.